AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 92 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,944,000 | +175.6% | 295,896 | +137.9% | 0.01% | +150.0% |
| Q1 2020 | $1,794,000 | -74.7% | 124,387 | -41.3% | 0.00% | -71.4% |
| Q4 2019 | $7,092,000 | +155.0% | 211,894 | +59.6% | 0.01% | +133.3% |
| Q3 2019 | $2,781,000 | -16.7% | 132,793 | -17.2% | 0.00% | 0.0% |
| Q2 2019 | $3,340,000 | +11.3% | 160,431 | +19.5% | 0.00% | 0.0% |
| Q1 2019 | $3,000,000 | -6.9% | 134,230 | -0.4% | 0.00% | -25.0% |
| Q4 2018 | $3,223,000 | -18.7% | 134,723 | -7.3% | 0.00% | 0.0% |
| Q3 2018 | $3,966,000 | +22.1% | 145,363 | +20.3% | 0.00% | +33.3% |
| Q2 2018 | $3,249,000 | -16.0% | 120,832 | -0.6% | 0.00% | -25.0% |
| Q1 2018 | $3,870,000 | +16.9% | 121,577 | +38.9% | 0.00% | +33.3% |
| Q4 2017 | $3,310,000 | +52.1% | 87,515 | -0.3% | 0.00% | +50.0% |
| Q3 2017 | $2,176,000 | +9.6% | 87,780 | -9.1% | 0.00% | 0.0% |
| Q2 2017 | $1,985,000 | -15.6% | 96,554 | -10.8% | 0.00% | 0.0% |
| Q1 2017 | $2,351,000 | +5.8% | 108,192 | -0.5% | 0.00% | 0.0% |
| Q4 2016 | $2,223,000 | +45.3% | 108,692 | +6.5% | 0.00% | 0.0% |
| Q3 2016 | $1,530,000 | +43.9% | 102,033 | +3.8% | 0.00% | +100.0% |
| Q2 2016 | $1,063,000 | -16.6% | 98,261 | +4.5% | 0.00% | 0.0% |
| Q1 2016 | $1,275,000 | -23.4% | 94,060 | +4.3% | 0.00% | -50.0% |
| Q4 2015 | $1,664,000 | -20.2% | 90,205 | +9.6% | 0.00% | -33.3% |
| Q3 2015 | $2,084,000 | – | 82,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |